Researchers developed BioCompNet, a dual-sequence AI system that automates body composition measurement from MRI scans for improved cardiometabolic risk management.
Key Details
- 1BioCompNet uses a dual-channel 2D U-Net framework to process fat- and water-sequence MRI for abdominal and thigh segmentation.
- 2It quantifies 15 key body composition components automatically, including muscle, bone, and various fat compartments.
- 3Tested on 503 subjects internally and 30 cases externally, it achieved mean Dice scores of 0.938 (abdomen) and 0.936 (thigh) with strong physician agreement (ICC 0.881–0.999).
- 4Automated processing takes 0.12 minutes per case, compared to 128.8 minutes manually, enabling large-scale studies.
- 5Limitations include the need for broader validation across populations, refinement of clinical integration, and multicenter studies for further generalizability.
Why It Matters
This workflow represents a significant advance in scalable, automated MRI quantitative analysis, potentially enabling precise risk assessment and management for cardiometabolic diseases. It reduces the labor required for body composition measurements, supporting both large-cohort research and future clinical deployment.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.